Biopharma just invested $270 million in hair loss. Here is what that money is buying — and what it isn't.

From Root to Ritual by Laritelle Organic. Something significant is happening in the hair loss pharmaceutical landscape. In late 2025, investor enthusiasm around hair loss therapies reached a new peak — Pelage Pharmaceuticals raised $120 million, Veradermics secured $150 million, and the question being asked across biopharma was whether hair loss could be the next GLP-1 moment: a category that had been chronically underfunded suddenly rece... Read the full article: https://laritelleorganic.com/blogs/news/biopharma-just-invested-270-million-in-hair-loss-here-is-what-that-money-is-buying-and-what-it-isnt